| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.09 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |